CUSIP: 92847N103
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,681,389
-
Share change
-
+5,000,245
-
Total reported value
-
$137,106,087
-
Price per share
-
$6.63
-
Number of holders
-
75
-
Value change
-
+$17,633,698
-
Number of buys
-
48
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 92847N103?
CUSIP 92847N103 identifies VTAE - VITAE PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 92847N103:
Institutional Holders of VITAE PHARMACEUTICALS INC - COM (VTAE) as of Q1 2016
As of 31 Mar 2016,
VITAE PHARMACEUTICALS INC - COM (VTAE) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,681,389 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BVF INC/IL, Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, AWM Investment Company, Inc., DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, BlackRock Fund Advisors, and VANGUARD GROUP INC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.